Aphria Acquires Latin American and Caribbean Cannabis Assets for $193 million in Stock from Scythian Biosciences

0
103

Aphria medical brands to gain exposure to over 300 million people, roughly 9 times the size of Canada LEAMINGTON, ON, July 17, 2018 /CNW/ – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) is proud to announce the Company’s planned expansion into Latin America and the Caribbean with the proposed acquisition of industry-leading companies in Colombia, Argentina, Jamaica and a right of first offer and refusal in respect of Brazil through a definitive share purchase agreement (the “Agreement”) with Scythian Biosciences Inc. (“Scythian”). Aphria will acquire 100% of the issued and outstanding common shares of LATAM Holdings Inc. (“LATAM Holdings”), a direct, wholly-owned subsidiary of Scythian (collectively, the “Transaction”). Highlights of the Transaction include: Colombia – Strategic Launch Pad into South America Colcanna S. Aphria Acquires Latin American and Caribbean Cannabis Assets for $193 million in Stock from Scythian Biosciences

thumbnail courtesy of newcannabisventures.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here